Hyperreninemic hypoaldosteronism: A possible etiological factor of septic shock-induced acute renal failure

Intensive Care Medicine

Volumn 29, Issue 10, 2003, Pages 1703-1709

  Du Cheyron, D ^a   Lesage, A ^a   Daubin, C ^a   Ramakers, M ^a   Charbonneau, P ^a  

^a CAEN UNIVERSITY HOSPITAL   (France)

Author keywords

Aldosterone; Intensive care unit; Outcome; Renal failure; Renin angiotensin system; Septic shock

Indexed keywords

ALDOSTERONE; CREATININE; FLUDROCORTISONE; HYDROCORTISONE; RENIN; SODIUM;

ACUTE KIDNEY FAILURE; ADULT; AGED; ALDOSTERONE BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CORTICOTROPIN TEST; CREATININE BLOOD LEVEL; CRITICAL ILLNESS; DISEASE COURSE; FEMALE; HUMAN; HYPERRENINEMIA; HYPOALDOSTERONISM; INTENSIVE CARE UNIT; KIDNEY TRANSPLANTATION; LOW DRUG DOSE; MALE; PLASMA RENIN ACTIVITY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SEPTIC SHOCK; SODIUM DEPLETION; SODIUM EXCRETION; UNIVERSITY HOSPITAL;

ADRENOCORTICOTROPIC HORMONE; ALDOSTERONE; FEMALE; HUMANS; HYPOALDOSTERONISM; KIDNEY FAILURE, ACUTE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENIN; SHOCK, SEPTIC;

EID: 0242593894     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-003-1986-6     Document Type: Article

References (35)

1. Angus DC, Wax RS (2001) Epidemiology of sepsis: an update. Crit Care Med 29:S109-S116
2. Brun-Buisson C, Doyon F, Carlet J, Dellamonica P, Gouin F, Lepoutre A, Mercier JC, Offenstadt G, Regnier B (1995) Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis. JAMA 274:968-974
3. Brun-Buisson C, Doyon F, Carlet J (1996) Bacteremia and severe sepsis in adults: a multicenter prospective survey in ICUs and wards of 24 hospitals. French Bacteremia-Sepsis Study Group. Am J Respir Crit Care Med 154:617-624
4. Rolih CA, Ober KP (1995) The endocrine response to critical illness. Med Clin North Am 79:211-224
5. Lamberts SW, Bruining HA, de Jong FH (1997) Corticosteroid therapy in severe illness. N Engl J Med 337:1285-1292
6. Annane D, Sebille V, Troche G, Raphael JC, Gajdos P, Bellissant E (2000) A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA 283:1038-1045
7. Bonvalet JP (1998) Regulation of sodium transport by steroid hormones. Kidney Int Suppl 65:S49-S56
8. Zipser RD, Davenport MW, Martin KL, Tuck ML, Warner NE, Swinney RR, Davis CL, Horton R (1981) Hyperreninemic hypoaldosteronism in the critically ill: a new entity. J Clin Endocrinol Metab 53:867-873
9. Findling JW, Waters VO, Raff H (1987) The dissociation of renin and aldosterone during critical illness. J Clin Endocrinol Metab 64:592-595
10. Davenport MW, Zipser RD (1983) Association of hypotension with hyperreninemic hypoaldosteronism in the critically ill patient. Arch Intern Med 143:735-737
11. (1992) American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864-874
12. Sealey JE (1991) Plasma renin activity and plasma prorenin assays. Clin Chem 37:1811-1819
13. Raff H, Findling JW (1990) Aldosterone control in critically ill patients: ACTH, metoclopramide, and atrial natriuretic peptide. Crit Care Med 18:915-920
14. McCabe WR, Jackson GG (1962) Gram negative bacteremia. I. Etiology and ecology. Arch Intern Med 110:847-855
15. Le Gall JR, Lemeshow S, Saulnier F (1993) A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 270:2957-2963
16. Marshall JC, Cook DJ, Christou NV, Bernard GR, Sprung CL, Sibbald WJ (1995) Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med 23:1638-1652
17. Takagi M, Atarashi K, Matsuoka H, Sugimoto T (1992) A biphasic effect of noradrenaline on renin release from rat juxtaglomerular cells in vitro is mediated by alpha 1-and beta-adrenoceptors. J Endocrinol 132:133-140
18. Saijonmaa O, Nyman T, Fyhrquist F (2001) Downregulation of angiotensin-converting enzyme by tumor necrosis factor-alpha and interleukin-1beta in cultured human endothelial cells. J Vasc Res 38:370-378
19. Smallridge RC, Chernow B, Snyder R, Zaloga GP, Burman KD (1985) Angiotensin-converting enzyme activity. A potential marker of tissue hypothyroidism in critical illness. Arch Intern Med 145:1829-1832
20. Oelkers W (1996) Adrenal insufficiency. N Engl J Med 335:1206-1212
21. Carey RM, Thorner MO, Ortt EM (1979) Effects of metoclopramide and bromocriptine on the renin-angiotensin-aldosterone system in man. Dopaminergic control of aldosterone. J Clin Invest 63:727-735
22. Missale C, Lombardi C, De Cotiis R, Memo M, Carruba MO, Spano PF (1989) Dopaminergic receptor mechanisms modulating the renin-angiotensin system and aldosterone secretion: an overview. J Cardiovasc Pharmacol 14 [Suppl 8]:S29-S39
23. Jong FH de, Mallios C, Jansen C, Scheck PA, Lamberts SW (1984) Etomidate suppresses adrenocortical function by inhibition of 11 beta-hydroxylation. J Clin Endocrinol Metab 59:1143-1147
24. Rydvall A, Brandstrom AK, Banga R, Asplund K, Backlund U, Stegmayr BG (2000) Plasma cortisol is often decreased in patients treated in an intensive care unit. Intensive Care Med 26:545-551
25. Martin C, Viviand X, Leone M, Thirion X (2000) Effect of norepinephrine on the outcome of septic shock. Crit Care Med 28:2758-2765
26. Brivet FG, Kleinknecht DJ, Loirat P, Landais PJ (1996) Acute renal failure in intensive care units-causes, outcome, and prognostic factors of hospital mortality; a prospective, multicenter study. French Study Group on Acute Renal Failure. Crit Care Med 24:192-198
27. Levy EM, Viscoli CM, Horwitz RI (1996) The effect of acute renal failure on mortality. A cohort analysis. JAMA 275:1489-1494
28. Thadhani R, Pascual M, Bonventre JV (1996) Acute renal failure. N Engl J Med 334:1448-1460
29. Annane D, Sebille V, Charpentier C, Bollaert PE, Francois B, Korach JM, Capellier G, Cohen Y, Azoulay E, Troche G, Chaumet-Riffaut P, Bellissant E (2002) Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288:862-871
30. Briegel J, Forst H, Haller M, Schelling G, Kilger E, Kuprat G, Hemmer B, Hummel T, Lenhart A, Heyduck M, Stoll C, Peter K (1999) Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. Crit Care Med 27:723-732
31. Bollaert PE, Charpentier C, Levy B, Debouverie M, Audibert G, Larcan A (1998) Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med 26:645-650
32. Radomski MW, Palmer RM, Moncada S (1990) Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci USA 87:10043-10047
33. Saito T, Takanashi M, Gallagher E, Fuse A, Suzaki S, Inagaki O, Yamada K, Ogawa R (1995) Corticosteroid effect on early beta-adrenergic down-regulation during circulatory shock: hemodynamic study and beta-adrenergic receptor assay. Intensive Care Med 21:204-210
34. Clore J, Schoolwerth A, Watlington CO (1992) When is cortisol a mineralocorticoid? Kidney Int 42:1297-1308
35. Farman N, Rafestin-Oblin ME (2001) Multiple aspects of mineralocorticoid selectivity. Am J Physiol Renal Physiol 280:F181-F192